TRESCALA Trademark

Trademark Overview

On Monday, January 27, 2020, a trademark application was filed for TRESCALA with the United States Patent and Trademark Office. The USPTO has given the TRESCALA trademark a serial number of 88774395. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 14, 2023. This trademark is owned by Pfizer Inc.. The TRESCALA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
trescala

General Information

Serial Number88774395
Word MarkTRESCALA
Filing DateMonday, January 27, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, August 14, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 14, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 7, 2023SOU EXTENSION 5 GRANTED
Wednesday, December 7, 2022SOU EXTENSION 5 FILED
Wednesday, December 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 7, 2022SOU TEAS EXTENSION RECEIVED
Saturday, June 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 23, 2022SOU EXTENSION 4 GRANTED
Thursday, June 23, 2022SOU EXTENSION 4 FILED
Thursday, June 23, 2022SOU TEAS EXTENSION RECEIVED
Monday, June 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 6, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 6, 2021SOU EXTENSION 3 GRANTED
Monday, December 6, 2021SOU EXTENSION 3 FILED
Monday, December 6, 2021SOU TEAS EXTENSION RECEIVED
Friday, June 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 2, 2021SOU EXTENSION 2 GRANTED
Wednesday, June 2, 2021SOU EXTENSION 2 FILED
Wednesday, June 2, 2021SOU TEAS EXTENSION RECEIVED
Saturday, December 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 3, 2020SOU EXTENSION 1 GRANTED
Thursday, December 3, 2020SOU EXTENSION 1 FILED
Thursday, December 3, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, July 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 19, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 9, 2020ASSIGNED TO EXAMINER
Tuesday, February 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2020NEW APPLICATION ENTERED

Related Keywords

trescala preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases